HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News

BRAF/MEK inhibitor therapy a preferred option for metastatic melanoma

March 26, 2018
NEW YORK — Combination therapy with BRAF and MEK inhibitors can confer long-term survival for patients with low-burden metastatic melanoma and…
Meeting NewsVideo

VIDEO: CAR T cells effective for non-Hodgkin lymphoma

March 13, 2018
NEW YORK — In this video commentary from HemOnc Today New York, Stephen J. Schuster, MD, discusses treatment with CD19-directed chimeric…
Meeting NewsVideo

VIDEO: Meeting offers insights into application of CAR T-cell therapy for hematologic malignancies

March 12, 2018
NEW YORK — In this video commentary from HemOnc Today New York, program co-chair David L. Porter, MD, discusses some of the take-home messages…
Meeting News

CAR T-cell therapy holds promise for multiple myeloma

March 12, 2018
NEW YORK — Cellular immunotherapies such as chimeric antigen receptor therapy are a promising approach for treatment of multiple myeloma…
Meeting News

Targeted therapies effective for acute lymphoblastic leukemia

March 10, 2018
NEW YORK — Targeted therapies such as inotuzumab and blinatumomab appear associated with high rates of complete molecular remission in patients…
Video

VIDEO: New data emerges for adjuvant treatment of melanoma

March 10, 2018
NEW YORK — In this video commentary from HemOnc Today New York, co-program chair Sanjiv S. Agarwala, MD, summarizes highlights from the…
Meeting NewsVideo

VIDEO: CAR T-cell therapy has ‘incredible potency’ in chronic lymphocytic leukemia

March 10, 2018
NEW YORK — In this video commentary from HemOnc Today New York, co-program chair David L. Porter, MD, discussed the use of chimeric antigen…
Meeting News

CAR T-cell therapy ‘holds great promise’ for advanced chronic lymphocytic leukemia

March 10, 2018
NEW YORK — Chimeric antigen receptor T-cell therapy “holds great promise” for patients with advanced relapsed or refractory chronic…
Meeting NewsVideo

VIDEO: Onset, frequency of toxicities vary between CTLA-4, PD-L1 agents

March 9, 2018
NEW YORK — In this video commentary from HemOnc Today New York, Young Kwang Chae, MD, MPH, MBA, discussed
Meeting NewsVideo

VIDEO: New data emerges for immunotherapy in frontline treatment of advanced lung cancer

March 9, 2018
NEW YORK — In this video commentary from HemOnc Today New York, Taofeek K. Owonikoko, MD, PhD, discussed the existing and emerging evidence of…

Meeting Calendar

HemOnc Today New York Presents - What oncologists need to know: A practical look at advances, challenges and trends

March 21, 2019 - March 23, 2019

Save $25 with priority code: Healio25